Avalyn Appoints Biopharmaceutical Industry Leader Kate Haviland to Board of Directors [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
Appointment adds extensive commercial, operational, and strategic leadership experience as Avalyn advances its pipeline of inhaled therapies for pulmonary fibrosis BOSTON, March 05, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc , a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory diseases, today announced the appointment of Kate Haviland to its Board of Directors. Ms. Haviland brings more than two decades of biopharmaceutical leadership experience, including her tenure as President and Chief Executive Officer of Blueprint Medicines, where she played a central role in the company's transformation from a discovery-stage organization to a fully integrated commercial enterprise. “We are thrilled to welcome Kate to our Board, adding another accomplished biopharma leader with deep commercial and strategic expertise to our team,” said Lyn Baranowski, CEO of Avalyn. “As we advance our lead assets through P
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Amgen Faces Rocatinlimab Halt And Rethinks Pipeline And Capital Priorities [Yahoo! Finance]Yahoo! Finance
- Podcast: Sanofi's head of clinical supply chain operations on evolving the clinical trial supply model [Yahoo! Finance]Yahoo! Finance
- Press Release: Sanofi's Board of Directors proposes the appointment of Christel Heydemann as an independent director [Yahoo! Finance]Yahoo! Finance
- Press Release: Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent directorGlobeNewswire
- Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 3/4/26 - Form 6-K
- 3/3/26 - Form 6-K
- 2/23/26 - Form 6-K
- SNY's page on the SEC website